Manufacturer record

Anrose Pharma: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Anrose Pharma (Himachal Pradesh) were declared Not of Standard Quality between August 2023 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Anrose Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2023 to Apr 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2023
3
Products affected
Description
Most common failure
Apr 2026
Latest alert

Flagged batches per year

2023 · 12024 · 12025 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Erythromycin Stearate Tablets IP ATG5K933Mfg 2025-11 · Exp 2027-10 DescriptionDescription DTL, PuducherryState lab Apr 2026
Doxycycline and Lactic Acid BacillusTablets(DOXYGLO-LB) ATG4G566Mfg 2024-07 · Exp 2026-06 The sample does not conform to the claim with respect to Assay of Doxycycline Hydrochloride IPAssay DTL,Jaipur (State Lab)State lab May 2025
RABEPP TABLETS (Rabeprazole Sodium Tablets IP) ATG2K135Mfg 2022-11 · Exp 2024-10 CONTENT OF RABEPRAZOLE SODIUM IM THE SAMPLE IS LESS (65.04% OF THE LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT 90.0% - 110.0%)Labelling State Lab MaharashtraState lab Jun 2024
Erythromycin Stearate Tablets (Enthrocin-500) ATG3A04 8Mfg 2023-01 · Exp 2024-12 DissolutionDissolution CDL KolkataCDSCO lab Aug 2023

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.